Skip to content
Biodatica
Start free

Takeda

Whittier, California

OncologyFiled/ApprovedListed · TAK

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

5w agoTrial registeredJun 12, 2026Source filing (opens the source filing in a new tab)

Momentum

97no change

Momentum 97 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE3 registered

    Apr 25, 2024

    Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) · TERMINATED · sponsor: Takeda · A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

    ClinicalTrials.gov · NCT06422377 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Nov 14, 2023

    Solid Tumors · TERMINATED · sponsor: Takeda · An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

    ClinicalTrials.gov · NCT05976334 (opens the source filing in a new tab)

  3. Trial

    PHASE3 registered

    Mar 27, 2023

    Hemophilia A · COMPLETED · sponsor: Takeda · A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

    ClinicalTrials.gov · NCT05707351 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Feb 10, 2023

    Lymphoma · ACTIVE_NOT_RECRUITING · sponsor: Takeda · A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

    ClinicalTrials.gov · NCT05673785 (opens the source filing in a new tab)

  5. Trial

    PHASE4 registered

    Nov 28, 2022

    T-Cell Lymphoma · COMPLETED · sponsor: Takeda · A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

    ClinicalTrials.gov · NCT05442554 (opens the source filing in a new tab)

  6. Trial

    PHASE2 registered

    Nov 16, 2022

    Multiple System Atrophy · COMPLETED · sponsor: Takeda · A Study of TAK-341 in Treatment of Multiple System Atrophy

    ClinicalTrials.gov · NCT05526391 (opens the source filing in a new tab)

  7. Trial

    PHASE4 registered

    Apr 21, 2022

    Hunter Syndrome · COMPLETED · sponsor: Takeda · A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India

    ClinicalTrials.gov · NCT05058391 (opens the source filing in a new tab)

  8. Trial

    PHASE3 registered

    Jun 30, 2021

    Crohn's Disease, Complex Perianal Fistula · TERMINATED · sponsor: Takeda · A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease

    ClinicalTrials.gov · NCT04701411 (opens the source filing in a new tab)

  9. Trial

    PHASE1/PHASE2 registered

    Feb 24, 2021

    Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL) · TERMINATED · sponsor: Takeda · A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    ClinicalTrials.gov · NCT04501614 (opens the source filing in a new tab)

  10. Trial

    PHASE4 registered

    Dec 22, 2020

    Crohn's Disease, Complex Perianal Fistula · TERMINATED · sponsor: Takeda · A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula

    ClinicalTrials.gov · NCT04118088 (opens the source filing in a new tab)

  11. Trial

    PHASE2 registered

    Nov 9, 2020

    Primary Immune Thrombocytopenia · COMPLETED · sponsor: Takeda · A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

    ClinicalTrials.gov · NCT04278924 (opens the source filing in a new tab)

  12. Trial

    PHASE3 registered

    Apr 19, 2019

    ALK+ Advanced NSCLC · COMPLETED · sponsor: Takeda · A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

    ClinicalTrials.gov · NCT03596866 (opens the source filing in a new tab)

  13. Trial

    PHASE2 registered

    Dec 16, 2016

    Multiple Myeloma, Lymphoma, Amyloidosis · COMPLETED · sponsor: Takeda · Ixazomib Rollover Study

    ClinicalTrials.gov · NCT02924272 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources